MEDICO

Medico Remedies Limited

WHO-GMP, ISO-certified pharmaceutical formulations manufacturer

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

medicoremediesindia.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹22.03
Market cap
183 Cr
Stock P/E
13.2
P/B
2.42
ROE (FY26)
17.4%
ROCE (FY26)
21.1%
Operating margin (FY26)
6.8%
Debt / equity (FY26)
0.25
OCF / EBITDA (FY26)
34.5%
OCF / EBITDA (3Y)
29.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Medico Remedies makes pharmaceutical formulations such as tablets, capsules and dry syrups at a plant in Palghar, Maharashtra, selling mainly to buyers outside India and also within India.

Company snapshot

106thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Debt-to-equity of 0.25x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Only 29% of operating profit came in as cash over the last three years — much of it is tied up in unpaid bills or stock.

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales42 Cr30 Cr41 Cr31 Cr39 Cr39 Cr41 Cr38 Cr53 Cr59 Cr57 Cr69 Cr
Operating expenses (approx.)39 Cr27 Cr37 Cr28 Cr37 Cr36 Cr35 Cr35 Cr50 Cr54 Cr50 Cr66 Cr
EBITDA3 Cr3 Cr5 Cr3 Cr2 Cr3 Cr7 Cr3 Cr3 Cr4 Cr7 Cr3 Cr
OPM %7.3%9.2%11.2%9.1%6.1%7.9%16.1%7.4%5.2%7.4%12.6%4.8%
Other income0.96 Cr0.27 Cr0.58 Cr0.29 Cr0.68 Cr1 Cr0.29 Cr0.66 Cr2 Cr0.68 Cr3 Cr1 Cr
Interest0.18 Cr0.22 Cr0.25 Cr0.18 Cr0.21 Cr0.28 Cr0.49 Cr0.28 Cr0.24 Cr0.39 Cr0.90 Cr0.41 Cr
Depreciation0.71 Cr0.72 Cr0.74 Cr0.75 Cr0.75 Cr0.76 Cr0.77 Cr0.77 Cr0.73 Cr0.79 Cr0.80 Cr0.72 Cr
Profit before tax3 Cr2 Cr4 Cr2 Cr2 Cr3 Cr6 Cr2 Cr3 Cr4 Cr8 Cr3 Cr
Tax %22.8%29.9%27.0%27.4%27.1%25.1%23.8%25.3%26.1%25.0%29.6%24.6%
Net profit2 Cr1 Cr3 Cr2 Cr2 Cr3 Cr4 Cr2 Cr3 Cr3 Cr6 Cr3 Cr
EPS (₹)₹0.29₹0.17₹0.37₹0.19₹0.19₹0.32₹0.52₹0.22₹0.31₹0.35₹0.71₹0.30

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales98 Cr89 Cr122 Cr121 Cr140 Cr145 Cr151 Cr206 CrSign in free for the trailing twelve months
Operating expenses (approx.)95 Cr86 Cr117 Cr114 Cr131 Cr132 Cr136 Cr189 CrSign in free for the trailing twelve months
EBITDA3 Cr3 Cr5 Cr7 Cr10 Cr13 Cr15 Cr17 CrSign in free for the trailing twelve months
OPM %2.8%3.2%4.3%6.0%6.9%8.9%9.9%8.3%Sign in free for the trailing twelve months
Other income2 Cr2 Cr1 Cr2 Cr4 Cr2 Cr3 Cr6 CrSign in free for the trailing twelve months
Interest0.98 Cr1 Cr0.92 Cr0.61 Cr0.75 Cr0.82 Cr1 Cr2 CrSign in free for the trailing twelve months
Depreciation2 Cr2 Cr2 Cr2 Cr3 Cr3 Cr3 Cr3 CrSign in free for the trailing twelve months
Profit before tax2 Cr2 Cr4 Cr7 Cr10 Cr11 Cr14 Cr18 CrSign in free for the trailing twelve months
Tax %27.8%26.4%29.7%25.4%28.3%26.9%25.3%27.4%Sign in free for the trailing twelve months
Net profit2 Cr2 Cr3 Cr5 Cr7 Cr8 Cr10 Cr13 CrSign in free for the trailing twelve months
EPS (₹)₹3.78₹3.93₹6.25₹2.95₹0.87₹1.00₹1.22₹1.58Sign in free for the trailing twelve months
Dividend payout %——0.0%0.0%0.0%0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital4 Cr4 Cr4 Cr17 Cr17 Cr17 Cr17 Cr17 Cr
Reserves24 Cr26 Cr28 Cr21 Cr27 Cr36 Cr46 Cr59 Cr
Borrowings————10 Cr8 Cr15 Cr19 Cr
Other liabilities48 Cr45 Cr43 Cr39 Cr34 Cr36 Cr43 Cr59 Cr
Total liabilities76 Cr75 Cr76 Cr76 Cr87 Cr96 Cr120 Cr153 Cr
Fixed assets (net)13 Cr15 Cr15 Cr16 Cr20 Cr20 Cr21 Cr20 Cr
CWIP————2 Cr1 Cr1 Cr3 Cr
Investments0.15 Cr0.15 Cr1 Cr0 Cr0 Cr2 Cr2 Cr2 Cr
Loans & advances————0.15 Cr0.20 Cr0.19 Cr0.28 Cr
Inventories16 Cr18 Cr15 Cr18 Cr20 Cr16 Cr27 Cr30 Cr
Trade receivables29 Cr24 Cr27 Cr31 Cr36 Cr50 Cr57 Cr82 Cr
Cash & bank0.61 Cr1 Cr3 Cr1 Cr0.91 Cr0.18 Cr1 Cr2 Cr
Other assets17 Cr17 Cr14 Cr10 Cr9 Cr7 Cr11 Cr14 Cr
Total assets76 Cr75 Cr76 Cr76 Cr87 Cr96 Cr120 Cr153 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity5 Cr0.97 Cr3 Cr6 Cr8 Cr2 Cr5 Cr6 Cr
Cash from investing-4 Cr-3 Cr-0.08 Cr-2 Cr-7 Cr-3 Cr-3 Cr-5 Cr
Cash from financing-0.55 Cr3 Cr-0.35 Cr-6 Cr-2 Cr-0.49 Cr-0.52 Cr-0.55 Cr
Net cash flow-0.06 Cr0.48 Cr2 Cr-2 Cr-0.25 Cr-0.73 Cr0.91 Cr0.81 Cr
Free cash flow (OCF − Capex)1 Cr-2 Cr0.47 Cr0.11 Cr8 Cr2 Cr5 Cr6 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %11.2%11.0%14.2%19.2%20.2%20.1%19.0%21.1%
ROE %5.6%5.5%8.0%13.1%16.5%15.8%16.2%17.4%
Debtor days10898829494125138145
Inventory days7597607872568774
Days payable————113108113121
Cash conversion cycle183195142172527311297
OCF / EBITDA %n.m.34.1%49.9%83.7%84.9%18.9%32.6%34.5%
OCF / EBITDA % (3 years)——78.5%62.9%76.2%56.0%41.3%29.4%
Debt / equity0.000.00230.00210.00040.220.150.240.25
Current ratio1.301.401.541.551.551.721.701.66
Net debt / EBITDA-0.22-0.50-0.54-0.160.920.610.910.99